Tag: ASCO2016

#ASCO16_650x450
June 28, 2016/Cancer/News & Insight

Top 10 ASCO Abstracts 2016

Favorites chosen by Cleveland Clinic’s Hematology and Medical Oncology staff

#ASCO16_650x450
June 6, 2016/Cancer/News & Insight

Tumor PD-L1 Expression Predicts Benefit from PD-1/PD-L1 Inhibition

New meta-analysis helps resolve the controversy

khorana-680×390
June 5, 2016/Cancer/News & Insight

New Pancreatic Cancer Treatment Guidelines Should Improve Care

ASCO panels provide evidence-based recommendations

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

#ASCO16_650x450
June 5, 2016/Cancer/News & Insight

Researchers Examine Response to Atezolizumab in Urothelial Cancer Patients

Immune and genetic biomarkers predict response rates

#ASCO16_650x450
June 5, 2016/Cancer/News & Insight

Brain Metastases: Evolving Concepts at ASCO 2016

Clinical approaches in the era of targeted therapy

BackPage 1 of 1Next
Advertisement
Ad